Metric Finance
LearnFAQ
LearnFAQ

Learn / PRTA

NASDAQ: PRTA

Prothena Corp Public Ltd co (PRTA) stock, explained like you're 5

Prothena Corp Public Ltd co trades on the Nasdaq under the ticker PRTA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 454 million dollars.

Ticker
PRTA
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 454 million dollars

Is Prothena Corp Public Ltd co a small, medium or large cap company?

No. Prothena Corp Public Ltd co is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 454 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Prothena Corp Public Ltd co makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves PRTA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • A 10% owner buys 100,000 Prothena (PRTA) shares, then another 10,000. (Stock Titan)
  • Insider Purchase: 10% owner at $PRTA Buys 100,000 Shares (Quiver Quantitative)
  • CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? (Yahoo Finance)
  • (PRTA) Risk Channels and Responsive Allocation (Stock Traders Daily)
  • PRTA Stock Rises Nearly 11% in Six Months: What's Driving It? (Yahoo Finance)

Follow PRTA in your daily brief

Each trading day at 5 PM ET we post what happened to Prothena Corp Public Ltd co and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow PRTA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Prothena Corp Public Ltd co stock

What does Prothena Corp Public Ltd co do?

Prothena Corp Public Ltd co trades on the Nasdaq under the ticker PRTA. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 454 million dollars.

What is the ticker symbol for Prothena Corp Public Ltd co?

Prothena Corp Public Ltd co trades under the ticker PRTA on the Nasdaq.

What is Prothena Corp Public Ltd co's market cap?

Prothena Corp Public Ltd co is a small cap stock with a market cap of about 454 million dollars.

How does Prothena Corp Public Ltd co make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves PRTA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow PRTA stock every day?

Add PRTA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow PRTA daily

A free brief on Prothena Corp Public Ltd co and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare PRTA: PRTA vs NVS, PRTA vs AZN, PRTA vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed